Boulder, Colorado - August 24, 2018 – Bolder BioTechnology is pleased to announce that Dr. Sanchita P. Ghosh of the Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, was selected to give an oral presentation on preclinical studies of BBT-059, Bolder BioTechnology’s long-acting interleukin-11 analog, at the Military Health System Research Symposium held August 20-23, 2018 at the Gaylord Palms Resort and Conference Center in Kissemmee, FL. The title of Dr. Ghosh’s presentation was “Radioprotective and radiomitigative efficacy by a single dose of BBT-059.”